F/M Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.15M	Buy	59,102 +788	+1%	+$28.7K	0.08%	230
2025 Q1	$2.11M	Buy	58,314 +16,310	+39%	+$591K	0.08%	222
2024 Q4	$1.77M	Buy	+42,004	New	+$1.77M	0.07%	239